File Download
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1056/NEJMc1902336
- Scopus: eid_2-s2.0-85065137292
- PMID: 31042845
- WOS: WOS:000467767800029
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura
| Title | Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura |
|---|---|
| Authors | |
| Keywords | drug efficacy drug safety human Letter phase 3 clinical trial (topic) |
| Issue Date | 2019 |
| Publisher | Massachusetts Medical Society. The Journal's web site is located at http://content.nejm.org/ |
| Citation | New England Journal of Medicine, 2019, v. 380 n. 18, article no. e32 How to Cite? |
| Description | Comment in Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. Reply - Comment On: N Engl J Med. 2019 Jan 24;380(4):335-346 [30625070] |
| Persistent Identifier | http://hdl.handle.net/10722/279509 |
| ISSN | 2021 Impact Factor: 176.079 2020 SCImago Journal Rankings: 19.889 |
| ISI Accession Number ID |
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Yang, Z | - |
| dc.contributor.author | McCaW, ZR | - |
| dc.contributor.author | Yin, G | - |
| dc.date.accessioned | 2019-11-01T07:18:44Z | - |
| dc.date.available | 2019-11-01T07:18:44Z | - |
| dc.date.issued | 2019 | - |
| dc.identifier.citation | New England Journal of Medicine, 2019, v. 380 n. 18, article no. e32 | - |
| dc.identifier.issn | 0028-4793 | - |
| dc.identifier.uri | http://hdl.handle.net/10722/279509 | - |
| dc.description | Comment in Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura. Reply - Comment On: N Engl J Med. 2019 Jan 24;380(4):335-346 [30625070] | - |
| dc.language | eng | - |
| dc.publisher | Massachusetts Medical Society. The Journal's web site is located at http://content.nejm.org/ | - |
| dc.relation.ispartof | New England Journal of Medicine | - |
| dc.rights | From New England Journal of Medicine, Zhao Yang, Zachary R. McCaw, Guosheng Yin, Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura (letter 1), vol. 380, article no. e32. Copyright © 2019 Massachusetts Medical Society. Reprinted with permission. | - |
| dc.subject | drug efficacy | - |
| dc.subject | drug safety | - |
| dc.subject | human | - |
| dc.subject | Letter | - |
| dc.subject | phase 3 clinical trial (topic) | - |
| dc.title | Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura | - |
| dc.type | Article | - |
| dc.identifier.email | Yin, G: gyin@hku.hk | - |
| dc.identifier.authority | Yin, G=rp00831 | - |
| dc.description.nature | published_or_final_version | - |
| dc.identifier.doi | 10.1056/NEJMc1902336 | - |
| dc.identifier.pmid | 31042845 | - |
| dc.identifier.scopus | eid_2-s2.0-85065137292 | - |
| dc.identifier.hkuros | 308624 | - |
| dc.identifier.volume | 380 | - |
| dc.identifier.issue | 18 | - |
| dc.identifier.spage | article no. e32 | - |
| dc.identifier.epage | article no. e32 | - |
| dc.identifier.isi | WOS:000467767800029 | - |
| dc.publisher.place | United States | - |
| dc.identifier.issnl | 0028-4793 | - |